218 related articles for article (PubMed ID: 1627786)
1. Tumor necrosis factor and interferon gamma: relevance for immune regulation and genetic predisposition to autoimmune disease.
Jacob CO
Semin Immunol; 1992 Jun; 4(3):147-54. PubMed ID: 1627786
[TBL] [Abstract][Full Text] [Related]
2. Genetic variability in tumor necrosis factor production: relevance to predisposition to autoimmune disease.
Jacob CO
Reg Immunol; 1992; 4(5):298-304. PubMed ID: 1290749
[TBL] [Abstract][Full Text] [Related]
3. Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells.
Matthys P; Vermeire K; Mitera T; Heremans H; Huang S; Schols D; De Wolf-Peeters C; Billiau A
J Immunol; 1999 Sep; 163(6):3503-10. PubMed ID: 10477624
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
Alleva DG; Kaser SB; Beller DI
J Immunol; 1998 Dec; 161(12):6878-84. PubMed ID: 9862720
[TBL] [Abstract][Full Text] [Related]
5. Immuno- and genetic therapy in autoimmune diseases.
Chernajovsky Y; Dreja H; Daly G; Annenkov A; Gould D; Adams G; Croxford JL; Baker D; Podhajcer OL; Mageed RA
Genes Immun; 2000 Jun; 1(5):295-307. PubMed ID: 11196690
[TBL] [Abstract][Full Text] [Related]
6. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
Qin HY; Chaturvedi P; Singh B
Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
[TBL] [Abstract][Full Text] [Related]
7. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
Fu Y; Nathan DM; Li F; Li X; Faustman DL
J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-based immunomodulation of autoimmune diseases: an overview.
Bach JF
Transplant Proc; 1996 Dec; 28(6):3023-5. PubMed ID: 8962173
[No Abstract] [Full Text] [Related]
9. Autoimmune disorders in diabetes.
Boitard C; Debray-Sachs M; Bach JF
Adv Nephrol Necker Hosp; 1986; 15():281-305. PubMed ID: 3082114
[TBL] [Abstract][Full Text] [Related]
10. Studies on the role of tumor necrosis factor in murine and human autoimmunity.
Jacob CO
J Autoimmun; 1992 Apr; 5 Suppl A():133-43. PubMed ID: 1503608
[TBL] [Abstract][Full Text] [Related]
11. Increased circulating CD11b+CD11c+ dendritic cells (DC) in aged BWF1 mice which can be matured by TNF-alpha into BLC/CXCL13-producing DC.
Ishikawa S; Nagai S; Sato T; Akadegawa K; Yoneyama H; Zhang YY; Onai N; Matsushima K
Eur J Immunol; 2002 Jul; 32(7):1881-7. PubMed ID: 12115607
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of IFN-gamma in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis.
Matthys P; Vermeire K; Heremans H; Billiau A
J Leukoc Biol; 2000 Oct; 68(4):447-54. PubMed ID: 11037964
[TBL] [Abstract][Full Text] [Related]
13. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
Ratkay LG; Tait B; Tonzetich J; Waterfield JD
J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961
[TBL] [Abstract][Full Text] [Related]
14. Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell.
Watanabe Y; Jacob CO
J Immunol; 1991 Feb; 146(3):899-905. PubMed ID: 1899098
[TBL] [Abstract][Full Text] [Related]
15. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
[TBL] [Abstract][Full Text] [Related]
16. Protooncogenes and autoimmunity.
Rapoport M; Mor A; Bistritzer T; Ramot Y; Levi O; Slavin S; Wysenbeek A
Isr J Med Sci; 1997 Apr; 33(4):262-6. PubMed ID: 9347876
[No Abstract] [Full Text] [Related]
17. Humanized animal models for autoimmune diseases.
Gregersen JW; Holmes S; Fugger L
Tissue Antigens; 2004 May; 63(5):383-94. PubMed ID: 15104670
[TBL] [Abstract][Full Text] [Related]
18. Utility of murine models for the study of spontaneous autoimmune type 1 diabetes.
Mathews CE
Pediatr Diabetes; 2005 Sep; 6(3):165-77. PubMed ID: 16109074
[No Abstract] [Full Text] [Related]
19. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans.
Iwakura Y; Saijo S; Kioka Y; Nakayama-Yamada J; Itagaki K; Tosu M; Asano M; Kanai Y; Kakimoto K
J Immunol; 1995 Aug; 155(3):1588-98. PubMed ID: 7636219
[TBL] [Abstract][Full Text] [Related]
20. Oncogene expression in autoimmune mice.
Mountz JD; Mushinski JF; Mark GE; Steinberg AD
J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
